40
Participants
Start Date
September 18, 2020
Primary Completion Date
September 29, 2023
Study Completion Date
September 29, 2023
Galcanezumab Prefilled Syringe
Galcanezumab will be supplied in preloaded syringes, each with a dose of 120 mg. Participants will first receive the first month's supply (240 mg) at study visit 2, and then will receive a two month supply at study visit 3. So, at study visit 2 and 3, each participant will get two pre-filled syringes.
Placebo
Placebo will be supplied in preloaded syringes, each with a dose of 120 mg. Participants will first receive the first month's supply (240 mg) at study visit 2, and then will receive a two month supply at study visit 3. So, at study visit 2 and 3, each participant will get two pre-filled syringes.
UCSF Medical Center at Mount Zion, San Francisco
Eli Lilly and Company
INDUSTRY
University of California, San Francisco
OTHER